Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Rande Is . . . HOME -- Ignore unavailable to you. Want to Upgrade?

To: Joe Smith who wrote (38602)	10/17/2000 5:29:05 PM
From: Softechie	Read Replies (1) \| Respond to of 57584

Are you going to cash? Bonds and treasuries?

To: Joe Smith who wrote (38602)	10/17/2000 6:02:19 PM
From: Jane4IceCream	Respond to of 57584

My one and only holding .....IMCL.....was green today by a small margin, but I believe will stay in the green because of the anticipated event that their phase II c225 cancer drug which has been very successful will get fast track approval by the FDA which has already looked at the studies. The stock just split Monday and no insiders or management have sold shares. Matter of fact, the director of the board just purchased 2000 sh at $92 pre-split on 28 Sept. Quite bullish if you ask me and you know how these stocks run AFTER a drug is approved for market like Immunex's Enbrel recently and that was afun ride to be in on. Sure, IMCL isnt 100% guaranteed that its c225 cancer drug will ever get to market, but boy howdy......insiders believe so, so do a few well established and large marketing partners in the same field that have already formed R&D and Marketing agreements with IMCL. My opinion only....I am usually right 1 out of 10 times. LOL Oh! P.S....Even Anthony@Pacific, the known shorter...is long IMCL:-) Jane